Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price shot up 5.3% during trading on Wednesday . The stock traded as high as $1.41 and last traded at $1.40. 151,027 shares changed hands during trading, an increase of 125% from the average session volume of 67,097 shares. The stock had previously closed at $1.33.
Cardiol Therapeutics Stock Up 5.3 %
The business’s 50 day moving average price is $1.35 and its two-hundred day moving average price is $1.76.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is the S&P 500 and How It is Distinct from Other Indexes
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
